To provide a combination of biomarkers, and a method of detecting brain injury or mild traumatic brain injury (mTBI) using the same.SOLUTION: Method of screening for disease or disorder is provided, comprising detecting biomarkers selected from a group consisting of GSTP, FABP, GFAP, NSE, GAP43, NFH, NFM, NFL, S100B, Tau, spectrin breakdown products, UCH-L1, VCAM, SAA, CCL23, peroxiredoxin 1 to 6, and NDKA under suitable conditions.SELECTED DRAWING: None
MARKERS AND THEIR USE IN BRAIN INJURY